In the announcement of 30/9/2022 little attention and...

In the announcement of 30/9/2022 little attention and information was given to the CBD comparator Epidiolex.other than to say this CBD formulation was the only FDA approved CBD product. It is in fact approved for the treatment of two of the most debilating forms of epilepsy.
Epidiolex is imported to the US from the UK. GW Pharmaceuticals was the British company behind the development of Epidiolex.
In May 2022 Jazz Pharmaceuticals acquired GW Pharmaceuticals for $7.2B.and the transaction was hailed as a major validation of the cannabinoid industry.
For AVE to demonstrate Its CBD product offered significant improvement over the gold standard CBD formulation was an impressive but unappreciated result.
Kens